« Return to News | Awards & Advancement

H3 Biomedicine names CEO

Thursday, November 3, 2011 10:27 AM

H3 Biomedicine has named Markus Warmuth, M.D., president and chief executive officer, effective immediately.

Warmuth joined the H3 Biomedicine team in August 2011 as chief scientific officer. Most recently, he had served as head of oncology drug discovery for the Novartis Institute for Biomedical Research (NIBR). In his role at NIBR, he directed broad aspects of the company's global oncology drug discovery portfolio from target discovery to clinical development.

"Markus provides the scientific vision of human cancer genetics revealing cancer dependencies and targeting those dependencies, even when they are viewed as challenging, by exploiting advances in modern asymmetric synthesis and chemical biology. He also brings industrial experience in leadership, management and cancer drug development. He is a perfect fit for the intensive, fast-paced environment of H3, where we want to bring hope and health urgently to patients living with cancer," said Stuart L. Schreiber, Ph.D., H3 scientific founder and founding director of Chemical Biology at the Broad Institute of Harvard and MIT.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.